» Articles » PMID: 31703684

Estimating the Effectiveness and Cost-effectiveness of Establishing Additional Endovascular Thrombectomy Stroke Centres in England: a Discrete Event Simulation

Overview
Publisher Biomed Central
Specialty Health Services
Date 2019 Nov 10
PMID 31703684
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We have previously modelled that the optimal number of comprehensive stroke centres (CSC) providing endovascular thrombectomy (EVT) in England would be 30 (net 6 new centres). We now estimate the relative effectiveness and cost-effectiveness of increasing the number of centres from 24 to 30.

Methods: We constructed a discrete event simulation (DES) to estimate the effectiveness and lifetime cost-effectiveness (from a payer perspective) using 1 year's incidence of stroke in England. 2000 iterations of the simulation were performed comparing baseline 24 centres to 30.

Results: Of 80,800 patients admitted to hospital with acute stroke/year, 21,740 would be affected by the service reconfiguration. The median time to treatment for eligible early presenters (< 270 min since onset) would reduce from 195 (IQR 155-249) to 165 (IQR 105-224) minutes. Our model predicts reconfiguration would mean an additional 33 independent patients (modified Rankin scale [mRS] 0-1) and 30 fewer dependent/dead patients (mRS 3-6) per year. The net addition of 6 centres generates 190 QALYs (95%CI - 6 to 399) and results in net savings to the healthcare system of £1,864,000/year (95% CI -1,204,000 to £5,017,000). The estimated budget impact was a saving of £980,000 in year 1 and £7.07 million in years 2 to 5.

Conclusion: Changes in acute stroke service configuration will produce clinical and cost benefits when the time taken for patients to receive treatment is reduced. Benefits are highly likely to be cost saving over 5 years before any capital investment above £8 million is required.

Citing Articles

Extending mechanical thrombectomy service provision to 24/7: a break-even analysis.

Balami J, Ford G, Buchan A, Gray A, Francesconi A, Collini P BMC Health Serv Res. 2024; 24(1):902.

PMID: 39113024 PMC: 11304785. DOI: 10.1186/s12913-024-11290-8.


Cost-effectiveness of improvement strategies for reperfusion treatments in acute ischemic stroke: a systematic review.

Nguyen C, Maas W, van der Zee D, Uyttenboogaart M, Buskens E, Lahr M BMC Health Serv Res. 2023; 23(1):315.

PMID: 36998011 PMC: 10064746. DOI: 10.1186/s12913-023-09310-0.


A cost-utility analysis comparing endovascular coiling to neurosurgical clipping in the treatment of aneurysmal subarachnoid haemorrhage.

Ahmed A, Ahmed Y, Duah-Asante K, Lawal A, Mohiaddin Z, Nawab H Neurosurg Rev. 2022; 45(5):3259-3269.

PMID: 36056977 PMC: 9492573. DOI: 10.1007/s10143-022-01854-9.


Discrete-Event Simulation to Model the Thrombolysis Process for Acute Ischemic Stroke Patients at Urban and Rural Hospitals.

Bulmer T, Volders D, Blake J, Kamal N Front Neurol. 2021; 12:746404.

PMID: 34777215 PMC: 8586711. DOI: 10.3389/fneur.2021.746404.


Regarding thrombectomy centre volumes and maximising access to thrombectomy services for stroke in England: A modelling study and mechanical thrombectomy for acute ischaemic stroke: An implementation guide for the UK.

White P, Ford G, James M, Allen M Eur Stroke J. 2021; 5(4):451-452.

PMID: 33598565 PMC: 7856595. DOI: 10.1177/2396987320971126.


References
1.
Caro J, Moller J . Advantages and disadvantages of discrete-event simulation for health economic analyses. Expert Rev Pharmacoecon Outcomes Res. 2016; 16(3):327-9. DOI: 10.1586/14737167.2016.1165608. View

2.
Albers G, Marks M, Kemp S, Christensen S, Tsai J, Ortega-Gutierrez S . Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018; 378(8):708-718. PMC: 6590673. DOI: 10.1056/NEJMoa1713973. View

3.
Fang C, Chang Y, Hsu H, Twu S, Chen K, Lin C . Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM. 2007; 100(2):97-105. DOI: 10.1093/qjmed/hcl141. View

4.
Igarashi A, Goto R, Suwa K, Yoshikawa R, Ward A, Moller J . Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation. Appl Health Econ Health Policy. 2015; 14(1):77-87. PMC: 4740570. DOI: 10.1007/s40258-015-0204-3. View

5.
Saver J, Goyal M, van der Lugt A, Menon B, Majoie C, Dippel D . Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA. 2016; 316(12):1279-88. DOI: 10.1001/jama.2016.13647. View